Breast Cancer, Male - 25 Studies Found

Completed : Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Biological: bevacizumab Given

Withdrawn : Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer
:
  • HER2-positive Breast Cancer
  • Male Breast Cancer
  • Biological: HER-2/neu peptide vaccine

Recruiting : Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
:
  • Breast Cancer
  • Breast Cancer, Male
  • Biological: Interferon-gamma (IFN-γ)

Active, not recruiting : FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
:
  • Male Breast Cancer
  • Stage II Breast Cancer
  • Radiation: fludeoxyglucose F 18

Active, not recruiting : Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
:
  • Male Breast Cancer
  • Recurrent Breast Cancer
  • Biological: adenovirus-p53 transduced dendritic cell (DC) vaccine

<<< Previous